By Editor , 22 September 2026
ESENTIA to Buy Mexican Pipeline Firm EOM for $400 Million

Mexico City – September 21, 2026 -- ESENTIA Energy Development, S.A.B. de C.V. (BMV: ESENTIA) has agreed to acquire 100% of Energía Occidente de México, S. de R.L. de C.V. (EOM) for a gross purchase price of US$400 million, the company announced.

The deal, signed today, gives ESENTIA the approximately 313-kilometer Guadalajara-Manzanillo natural gas pipeline system, which runs from Jalisco to the Pacific port of Manzanillo, Colima.

By Editor , 22 September 2026
GE Aerospace Board Declares $0.47 Per Share Quarterly Dividend

Cincinnati – September 21, 2026 -- GE Aerospace's Board of Directors declared a $0.47 per share dividend on the company's outstanding common stock, the aerospace propulsion and services group announced.

Dividend payment set for October 26, 2026

The dividend is payable on October 26, 2026, to shareholders of record as of the close of business on October 5, 2026. The ex-dividend date is also set for October 5, 2026, meaning investors purchasing shares on or after that date will not qualify for this payout.

By Editor , 22 September 2026
Sun Life to Redeem $500 Million in Subordinated Debentures Nov. 18

Toronto – September 21, 2026 -- Sun Life Financial Inc. (TSX: SLF) (NYSE: SLF) will redeem all $500 million principal amount of its outstanding Series 2021-1 Subordinated Unsecured 2.46% Fixed/Floating Debentures on November 18, 2026, funding the buyback entirely from existing cash and liquid assets.

By Editor , 22 September 2026
Lockheed Martin Wins $1.2B Army Deal for PrSM Increment 2 Missile

Dallas – September 21, 2026 -- The U.S. Army has awarded Lockheed Martin (NYSE:LMT) an indefinite delivery, indefinite quantity contract worth up to $1.2 billion to produce Increment 2 of the Precision Strike Missile (PrSM), following a second flight test that demonstrated the missile's ability to engage moving maritime targets.

By Editor , 22 September 2026

Warren, N.J. – September 21, 2026 -- PTC Therapeutics, Inc. (NASDAQ: PTCT) has completed its acquisition of ST-920, a BLA-stage, one-time AAV gene therapy for Fabry disease, from Sangamo Therapeutics, Inc.

PTC targets Q4 2026 completion of rolling BLA submission for accelerated approval

The company confirmed that a rolling Biologics License Application submission to the FDA seeking accelerated approval of ST-920, also known as isaralgagene civaparvovec, is expected to be completed in the fourth quarter of 2026.

By Editor , 22 September 2026
Sun Life Consolidates Preferred Shares, Sets 5.519% Dividend Rate

Toronto – September 21, 2026 -- Sun Life Financial Inc. (TSX: SLF) (NYSE: SLF) will have 8,000,000 Class A Non-cumulative Rate Reset Preferred Shares Series 10R issued and outstanding as of September 30, 2026, after a share conversion process eliminated its floating-rate Series 11QR class entirely.

By Editor , 22 September 2026
Flexent Posts $14M Q2 Client Funding Growth Across Five Sectors

Gloucester, Va. – September 21, 2026 -- Flexent, a national provider of invoice factoring and asset-based lending, grew total client funding by more than $14 million in the second quarter, backing businesses in transportation and logistics, precision manufacturing, IT consulting, healthcare transportation, and wholesale distribution.

By Editor , 22 September 2026
Keystone RV Posts Strongest Hershey Retail Results Since Pandemic

Goshen, Indiana – September 21, 2026 -- Keystone RV Company recorded its strongest retail sales performance at America's Largest RV Show in Hershey, Pennsylvania since before the pandemic, driven by coordinated preparation between the manufacturer and its dealer network.

By Editor , 22 September 2026
Nuveen Green Capital Closes $23.2M First-Ever C-PACE Deal in New Hampshire

Lebanon, New Hampshire – September 21, 2026 -- Nuveen Green Capital (NGC) has closed $23.2 million in Commercial Property Assessed Clean Energy (C-PACE) financing for The Brickyard development in Lebanon, New Hampshire, marking the first C-PACE transaction ever completed in the state.

By Editor , 22 September 2026
ASRC Federal Wins $494M DCSA Vetting Contract

Reston, Va. – September 21, 2026 -- ASRC Federal's subsidiary, ASRC Research and Technology Solutions (ARTS), has secured a $494 million, five-year contract from the Defense Counterintelligence and Security Agency (DCSA) to support the Case Processing Operation Center (CPOC) 2.0 program.